Head-To-Head Contrast: Cotiviti (COTV) and Its Peers

Cotiviti (NYSE: COTV) is one of 20 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it compare to its rivals? We will compare Cotiviti to related companies based on the strength of its profitability, earnings, analyst recommendations, valuation, dividends, risk and institutional ownership.

Analyst Ratings

This is a summary of recent ratings for Cotiviti and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cotiviti 0 4 6 0 2.60
Cotiviti Competitors 90 441 836 13 2.56

Cotiviti presently has a consensus target price of $40.38, suggesting a potential upside of 25.35%. As a group, “Medical Software & Technology Services” companies have a potential upside of 17.34%. Given Cotiviti’s stronger consensus rating and higher probable upside, analysts clearly believe Cotiviti is more favorable than its rivals.

Institutional and Insider Ownership

86.2% of Cotiviti shares are owned by institutional investors. Comparatively, 62.7% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 15.8% of Cotiviti shares are owned by insiders. Comparatively, 26.5% of shares of all “Medical Software & Technology Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk and Volatility

Cotiviti has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, Cotiviti’s rivals have a beta of 1.15, meaning that their average share price is 15% more volatile than the S&P 500.

Earnings and Valuation

This table compares Cotiviti and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Cotiviti $625.16 million $48.85 million 33.21
Cotiviti Competitors $413.57 million -$24.55 million 408.20

Cotiviti has higher revenue and earnings than its rivals. Cotiviti is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


This table compares Cotiviti and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cotiviti 13.86% 13.61% 6.62%
Cotiviti Competitors -14.47% -7.27% 0.23%


Cotiviti beats its rivals on 8 of the 13 factors compared.

About Cotiviti

Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.

Receive News & Ratings for Cotiviti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply